Literature DB >> 19734826

Trichomoniasis and other sexually transmitted infections: results from the 2001-2004 National Health and Nutrition Examination Surveys.

Jenifer E Allsworth1, Jane Alyce Ratner, Jeffrey F Peipert.   

Abstract

BACKGROUND: To estimate the association between Trichomonas vaginalis infection (TV) and 6 sexually transmitted infections: chlamydia, gonorrhea, herpes simplex virus (Types 1 and 2), syphilis, and human immunodeficiency virus (HIV) in a nationally representative sample.
METHODS: We used data from the National Health and Nutrition Examination Survey combining the 2001-2002 and 2003-2004 waves to estimate the association between TV and sexually transmitted infections (STIs) among women in the civilian, noninstitutionalized US population. The final sample included data from 3648 women, which when weighted, represents the experience of 65,563,298 US women between the ages of 14 and 49. Crude and adjusted relative risks were estimated using logistic regression for rare STIs (<10%; chlamydia, syphilis, and HIV) and Poisson regression for common STIs (herpes simplex virus [HSV] Types 1 and 2). Statistical analyses were conducted using Stata (version 9.2).
RESULTS: The prevalence of trichomoniasis was 3.2% with over 80% of cases asymptomatic in the past month. All STIs examined (chlamydia, gonorrhea, HSV-1, HSV-2, syphilis, and HIV) were more common among women with a positive test for trichomoniasis. HSV-1 (RR = 1.20, 95% CI: 1.09, 1.34) and HSV-2 (RR = 1.51, 95% CI: 2.32, 3.23) were significantly associated with trichomoniasis after adjusting for race/ethnicity, age, and recent sexual partners. In crude analyses, a positive treponemal test was 6 times (95% CI: 2.07, 18.8) more common and HIV was 13 times (95% CI: 2.88, 59.1) more common among women with trichomoniasis, but these estimates were greatly attenuated after adjustment for potential confounders.
CONCLUSION: Trichomoniasis is significantly associated with concurrent STI.

Entities:  

Mesh:

Year:  2009        PMID: 19734826      PMCID: PMC3117286          DOI: 10.1097/OLQ.0b013e3181b38a4b

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  31 in total

1.  Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection.

Authors:  M A Klebanoff; J C Carey; J C Hauth; S L Hillier; R P Nugent; E A Thom; J M Ernest; R P Heine; R J Wapner; W Trout; A Moawad; K J Leveno; M Miodovnik; B M Sibai; J P Van Dorsten; M P Dombrowski; M J O'Sullivan; M Varner; O Langer; D McNellis; J M Roberts
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

2.  Estimating the relative risk in cohort studies and clinical trials of common outcomes.

Authors:  Louise-Anne McNutt; Chuntao Wu; Xiaonan Xue; Jean Paul Hafner
Journal:  Am J Epidemiol       Date:  2003-05-15       Impact factor: 4.897

3.  Herpes simplex virus type 1 infection: a sexually transmitted infection of adolescence?

Authors:  F M Cowan; A Copas; A M Johnson; R Ashley; L Corey; A Mindel
Journal:  Sex Transm Infect       Date:  2002-10       Impact factor: 3.519

4.  The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1.

Authors:  C C Wang; R S McClelland; M Reilly; J Overbaugh; S R Emery; K Mandaliya; B Chohan; J Ndinya-Achola; J Bwayo; J K Kreiss
Journal:  J Infect Dis       Date:  2001-02-28       Impact factor: 5.226

5.  Comparison of the Serodia Treponema pallidum particle agglutination, Captia Syphilis-G, and SpiroTek Reagin II tests with standard test techniques for diagnosis of syphilis.

Authors:  V Pope; M B Fears; W E Morrill; A Castro; S E Kikkert
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

6.  TaqMan-based detection of Trichomonas vaginalis DNA from female genital specimens.

Authors:  J A Jordan; D Lowery; M Trucco
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

7.  Six-year study of the incidence of herpes in genital and nongenital cultures in a central Kentucky medical center patient population.

Authors:  J A Ribes; A D Steele; J P Seabolt; D J Baker
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

8.  Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis.

Authors:  Karen A Wendel; Emily J Erbelding; Charlotte A Gaydos; Anne M Rompalo
Journal:  Clin Infect Dis       Date:  2002-08-06       Impact factor: 9.079

9.  Emergence of herpes simplex type 1 as the main cause of recurrent genital ulcerative disease in women in Northern Ireland.

Authors:  P V Coyle; H J O'Neill; D E Wyatt; C McCaughey; S Quah; M O McBride
Journal:  J Clin Virol       Date:  2003-05       Impact factor: 3.168

10.  Epidemiological features of women with trichomoniasis in Auckland sexual health clinics: 1998-99.

Authors:  Min Lo; Murray Reid; Michael Brokenshire
Journal:  N Z Med J       Date:  2002-08-09
View more
  54 in total

1.  Incidence of sexually transmitted infections among hazardously drinking women after incarceration.

Authors:  Michael D Stein; Celeste M Caviness; Bradley J Anderson
Journal:  Womens Health Issues       Date:  2011-08-10

Review 2.  Mycoplasma genitalium and Trichomonas vaginalis: addressing disparities and promoting public health control of two emerging sexually transmitted infections.

Authors:  Faye Korich; Neha G Reddy; Maria Trent
Journal:  Curr Opin Pediatr       Date:  2020-08       Impact factor: 2.856

3.  Trichomonas vaginalis and Human Immunodeficiency Virus Coinfection Among Women Under Community Supervision: A Call for Expanded T. vaginalis Screening.

Authors:  Alissa Davis; Anindita Dasgupta; Dawn Goddard-Eckrich; Nabila El-Bassel
Journal:  Sex Transm Dis       Date:  2016-10       Impact factor: 2.830

Review 4.  The role of bacterial vaginosis and trichomonas in HIV transmission across the female genital tract.

Authors:  Paria Mirmonsef; Laurie Krass; Alan Landay; Gregory T Spear
Journal:  Curr HIV Res       Date:  2012-04       Impact factor: 1.581

5.  Prevalence of Trichomonas vaginalis and coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as determined by the Aptima Trichomonas vaginalis nucleic acid amplification assay.

Authors:  C C Ginocchio; K Chapin; J S Smith; J Aslanzadeh; J Snook; C S Hill; C A Gaydos
Journal:  J Clin Microbiol       Date:  2012-05-23       Impact factor: 5.948

6.  Clinical performance of the Solana® Point-of-Care Trichomonas Assay from clinician-collected vaginal swabs and urine specimens from symptomatic and asymptomatic women.

Authors:  C A Gaydos; J Schwebke; J Dombrowski; J Marrazzo; J Coleman; B Silver; M Barnes; L Crane; P Fine
Journal:  Expert Rev Mol Diagn       Date:  2017-01-29       Impact factor: 5.225

7.  In vitro efficacy of curcumin on Trichomonas vaginalis.

Authors:  Benjamin Wachter; Michael Syrowatka; Andreas Obwaller; Julia Walochnik
Journal:  Wien Klin Wochenschr       Date:  2014-03-12       Impact factor: 1.704

8.  Prevalence of sexually transmitted infections in at-risk adolescent females at a comprehensive, stand-alone adolescent health center in New York City.

Authors:  Risa L Yavorsky; Dominic Hollman; John Steever; Christine Soghomonian; Angela Diaz; Howard Strickler; Nicolas Schlecht; Robert D Burk; Christopher N Ochner
Journal:  Clin Pediatr (Phila)       Date:  2014-05-07       Impact factor: 1.168

9.  Quantity, not frequency, of alcohol use moderates the association between multiple sexual partners and Trichomonas vaginalis among women attending an urban STD clinic.

Authors:  Lori A J Scott-Sheldon; Theresa E Senn; Kate B Carey; Marguerite A Urban; Michael P Carey
Journal:  Sex Transm Infect       Date:  2013-04-11       Impact factor: 3.519

10.  Rapid Diagnosis of Trichomonas vaginalis by Testing Vaginal Swabs in an Isothermal Helicase-Dependent AmpliVue Assay.

Authors:  Charlotte A Gaydos; Marcia Hobbs; Jeanne Marrazzo; Jane Schwebke; Jenell S Coleman; Billie Masek; Laura Dize; Dan Jang; Jenny Li; Max Chernesky
Journal:  Sex Transm Dis       Date:  2016-06       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.